These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison. Galatius S; Gustafsson F; Atar D; Hildebrandt PR Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort. Tang CH; Wang CC; Chen TH; Hong CY; Sue YM J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790 [TBL] [Abstract][Full Text] [Related]
4. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial. Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086 [TBL] [Abstract][Full Text] [Related]
5. Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. Taniguchi T; Ohtani T; Mizote I; Kanzaki M; Ichibori Y; Minamiguchi H; Asano Y; Sakata Y; Komuro I J Cardiol; 2013 Jun; 61(6):417-22. PubMed ID: 23548374 [TBL] [Abstract][Full Text] [Related]
6. Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis. Maekawa M; Takahashi A; Miki Y Ther Apher Dial; 2017 Oct; 21(5):513-514. PubMed ID: 28524584 [No Abstract] [Full Text] [Related]
8. Peyronie disease in association with carvedilol: a case report. Bell DS South Med J; 2008 Nov; 101(11):1157-8. PubMed ID: 19088529 [TBL] [Abstract][Full Text] [Related]
9. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease. Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798 [TBL] [Abstract][Full Text] [Related]
10. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population. Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L; Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495 [TBL] [Abstract][Full Text] [Related]
11. Possible adverse skin reaction to carvedilol. Simpson SH; Tsuyuki RT; Gutierrez R; Lo A; Teo KK Can J Cardiol; 1998 Oct; 14(10):1277-9. PubMed ID: 9852941 [TBL] [Abstract][Full Text] [Related]